Education
About Us
Working with TipRanks
Follow Us
Alphamab Oncology (HK:9966)
:9966
9966 Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
9966 Stock 12 Month Forecast
Average Price Target
HK$13.65
▲(42.48% Upside)
| Highest Price TargetHK$14.30 | Average Price TargetHK$13.65 | Lowest Price TargetHK$13.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Unknown Analyst
GF SecuritiesNot Ranked
GF Securities
HK$12.89
Buy
34.55%
Upside
Reiterated
06/12/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Unknown Analyst
GF SecuritiesNot Ranked
GF Securities
HK$12.89
Buy
34.55%
Upside
Reiterated
06/12/25
9966 Analyst Recommendation Trends
Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
3
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
3
3
Each month's total comprises the sum of three months' worth of ratings.
9966 Financial Forecast
9966 Stock Forecast FAQ
What is HK:9966’s average 12-month price target, according to analysts?
Based on analyst ratings, Alphamab Oncology’s 12-month average price target is 13.65.
What is HK:9966’s upside potential, based on the analysts’ average price target?
Alphamab Oncology has 42.48% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Alphamab Oncology a Buy, Sell or Hold?
Alphamab Oncology has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Alphamab Oncology’s share price target?
The average share price target for Alphamab Oncology is 13.65. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$14.30 ,and the lowest forecast is HK$13.00. The average share price target represents 42.48% Increase from the current price of HK$9.58.
The highest analyst share price target is HK$14.30 ,and the lowest forecast is HK$13.00. The average share price target represents 42.48% Increase from the current price of HK$9.58.
What do analysts say about Alphamab Oncology?
Alphamab Oncology’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of Alphamab Oncology?
To buy shares of HK:9966, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.